Latest Atheroma Stories
Researchers report that they have designed nanoparticles that find clots and make them visible to a new kind of X-ray technology.
Results from the PROSPECT clinical trial shed new light on the types of vulnerable plaque that are most likely to cause sudden, unexpected adverse cardiac events, and on the ability to identify them through imaging techniques before they occur.
The discovery that high levels of high-density lipoprotein (HDL) cholesterol (the "good cholesterol") is associated with reduced risk of cardiovascular disease has fostered intensive research to modify HDL levels for therapeutic gain.
It has been well-known that high levels of high-density lipoprotein (HDL) cholesterol, the "good" kind, are associated with a lower risk of heart disease.
For decades, doctors have looked at fitness levels, weight, and overall health risk factors for heart disease and stroke.
Atherosclerosis is the leading cause of death in the developed world.
Plaque in a heart artery looks threatening, but cardiologists know that many of these buildups will not erupt, dislodge and block a vessel, causing a heart attack that can be fatal.
New findings suggesting that bacteria in the mouth and/or intestine can affect the the outcome pathogenesis of atherosclerosis and lead to new treatment strategies.
Researchers from Mount Sinai School of Medicine have for the first time developed a way to visualize coronary artery plaques vulnerable to rupture using multi-color computed tomography (CT), an innovation that will lead to better and earlier diagnosis of cardiovascular disease.
- A volcanic mudflow.